Cardiac Biotech Solutions (CBSC) Short Interest Ratio & Short Volume

Short interest is the volume of Cardiac Biotech Solutions shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 20,400 shares of CBSC short. Learn More on Cardiac Biotech Solutions' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CBSC shares currently have a short interest ratio of 1.0. Learn More on Cardiac Biotech Solutions's short interest ratio.

Cardiac Biotech Solutions saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 20,400 shares, an increase of 92.5% from the previous total of 10,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "medical equipment" compare to Cardiac Biotech Solutions: IRIDEX Corporation (2.54%), Allurion Technologies, Inc. (3.76%), Vaso Corporation (0.00%), United Health Products, Inc. (0.03%), Retractable Technologies, Inc. (0.17%), Guided Therapeutics Inc. (0.02%), NeurAxis, Inc. (0.35%), Nexalin Technology, Inc. (0.48%), NexGel, Inc. (0.99%), Inspira Technologies OXY B.H.N. Ltd. (2.31%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks.

Short selling CBSC is an investing strategy that aims to generate trading profit from Cardiac Biotech Solutions as its price is falling. CBSC shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Cardiac Biotech Solutions occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CBSC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CBSC, twice per month. The most recent reporting period available is July, 15 2025.